Compounds > alginate--aluminium-hydroxide--magnesium-trisilicate--sodium-bicarbonate-drug-combination

alginate--aluminium-hydroxide--magnesium-trisilicate--sodium-bicarbonate-drug-combination and Anemia--Hypochromic

alginate--aluminium-hydroxide--magnesium-trisilicate--sodium-bicarbonate-drug-combination has been researched along with Anemia--Hypochromic* in 1 studies

Other Studies

1 other study(ies) available for alginate--aluminium-hydroxide--magnesium-trisilicate--sodium-bicarbonate-drug-combination and Anemia--Hypochromic

ArticleYear
[Bioavailability of orally administered iron. Effects of alginate/antacid administration].
    Minerva medica, 1992, Volume: 83, Issue:3

    Sideropenia is often encountered in medical practice; the iron preparation that presents the highest bioavailability is unquestionably iron sulphate. This compound, however, frequently provokes numerous side-effects that induce the patient to suspend treatment. Here it is shown that the bioavailability of the drug is not changed after intake of alginic acid, while side-effects are considerably reduced.

    Topics: Administration, Oral; Adolescent; Adult; Aged; Alginates; Aluminum Hydroxide; Anemia, Hypochromic; Antacids; Bicarbonates; Biological Availability; Drug Combinations; Female; Ferrous Compounds; Humans; Iron; Male; Middle Aged; Silicic Acid; Sodium Bicarbonate

1992